Lisa Rojkjaer insider trades

Open-market stock purchases and sales by Lisa Rojkjaer, EVP, Chief Medical Officer at Rigel Pharmaceuticals Inc, from SEC Form 4 filings since Mar 26, 2021.

Recent trades

DateStockTradeValue
Jun 17, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Jun 17, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Jun 1, 2026RIGL Rigel Pharmaceuticals IncSold (not open market)$25.4K
Feb 17, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Feb 10, 2026RIGL Rigel Pharmaceuticals IncSold (not open market)$130K

Companies traded

  • RIGL Rigel Pharmaceuticals Inc: other filings, last Jun 17, 2026
  • VIRX Viracta Therapeutics, Inc: 7 sales, last Mar 16, 2023

Get free alerts when Lisa Rojkjaer files a new trade →